Opioid Induced and Exacerbated Constipation Importance, Definitions and Rationale for a Change in Nomenclature
This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners and physician assistants.
At the conclusion of this activity, participants will be able to:
- • Review current and emerging treatment options for opioid induced and exacerbated constipation
• Discuss the definition of opioid exacerbated constipation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and The Gastrointestinal Health Foundation (GIHF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Statement
Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207. This program is accredited for 0.5 contact hours which includes 0.5 hour(s) of pharmacology. Program ID #5566.
Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and The Gastrointestinal Health Foundation (GIHF) have no relationships to disclose.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Amy Kassebaum, PA-C has no financial relationships to disclose.
Amy Kassebaum, PA-C
This program has expired. CME credit is no longer available.
Release Date: 12/21/2017
Expiration Date: 12/21/2018
Webcast must be viewed in its entirety to claim credit.
This activity supported by an educational grant from Intercept, Merck and Salix.